These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 7667183)

  • 1. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate.
    Pardridge WM; Kang YS; Buciak JL; Yang J
    Pharm Res; 1995 Jun; 12(6):807-16. PubMed ID: 7667183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor.
    Coloma MJ; Lee HJ; Kurihara A; Landaw EM; Boado RJ; Morrison SL; Pardridge WM
    Pharm Res; 2000 Mar; 17(3):266-74. PubMed ID: 10801214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor.
    Wu D; Yang J; Pardridge WM
    J Clin Invest; 1997 Oct; 100(7):1804-12. PubMed ID: 9312181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody-Iduronidase Fusion Protein.
    Boado RJ; Pardridge WM
    Mol Pharm; 2017 Apr; 14(4):1271-1277. PubMed ID: 28279069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery.
    Pardridge WM; Kang YS; Buciak JL
    Pharm Res; 1994 May; 11(5):738-46. PubMed ID: 8058646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very High Plasma Concentrations of a Monoclonal Antibody against the Human Insulin Receptor Are Produced by Subcutaneous Injection in the Rhesus Monkey.
    Boado RJ; Hui EK; Lu JZ; Pardridge WM
    Mol Pharm; 2016 Sep; 13(9):3241-6. PubMed ID: 27513815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin Receptor Antibody-α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts.
    Boado RJ; Lu JZ; Hui EK; Lin H; Pardridge WM
    Mol Pharm; 2016 Apr; 13(4):1385-92. PubMed ID: 26910785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of blood-brain barrier transport of glial-derived neurotrophic factor (GDNF) and an IgG-GDNF fusion protein in the rhesus monkey.
    Boado RJ; Pardridge WM
    Drug Metab Dispos; 2009 Dec; 37(12):2299-304. PubMed ID: 19741036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
    Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
    Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein.
    Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM
    J Biotechnol; 2010 Mar; 146(1-2):84-91. PubMed ID: 20100527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor.
    Boado RJ; Lu JZ; Hui EK; Sumbria RK; Pardridge WM
    Biotechnol Bioeng; 2013 May; 110(5):1456-65. PubMed ID: 23192358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human blood-brain barrier transferrin receptor.
    Pardridge WM; Eisenberg J; Yang J
    Metabolism; 1987 Sep; 36(9):892-5. PubMed ID: 3306281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-Brain Barrier Transport, Plasma Pharmacokinetics, and Neuropathology Following Chronic Treatment of the Rhesus Monkey with a Brain Penetrating Humanized Monoclonal Antibody Against the Human Transferrin Receptor.
    Pardridge WM; Boado RJ; Patrick DJ; Ka-Wai Hui E; Lu JZ
    Mol Pharm; 2018 Nov; 15(11):5207-5216. PubMed ID: 30226787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global non-viral gene transfer to the primate brain following intravenous administration.
    Zhang Y; Schlachetzki F; Pardridge WM
    Mol Ther; 2003 Jan; 7(1):11-8. PubMed ID: 12573613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain barrier transport of reduced folic acid.
    Wu D; Pardridge WM
    Pharm Res; 1999 Mar; 16(3):415-9. PubMed ID: 10213373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
    Pardridge WM; Boado RJ
    Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration.
    Pardridge WM; Wu D; Sakane T
    Pharm Res; 1998 Apr; 15(4):576-82. PubMed ID: 9587954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system.
    Wu D; Song BW; Vinters HV; Pardridge WM
    J Drug Target; 2002 May; 10(3):239-45. PubMed ID: 12075825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.